A big fat fight has just broken out in India
With the launch of Wegovy by Novo Nordisk in India, the country’s obesity drugs sector is all set…
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s…
Medicines and advertising regulators examine Ozempic maker’s Irish ads
We need your help now Support from readers like you keeps The Journal open. You are visiting us…
Are ‘Ozempic feet’ real? Here’s what to know
People taking Ozempic and other popular GLP-1 weight loss drugs may expect to feel nausea or stomach pain.…
Novo Nordisk on the back foot ahead of earnings – The Irish Times
Novo Nordisk reports earnings on Wednesday, and for once, Wall Street isn’t holding its breath. Once celebrated for…
Patients struggle as compounded GLP-1 access rapidly shrinks
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many…
Cheaper Wegovy, Ozempic copies restricted by federal court order
Ozempic warning: Experts warn of side effects from weight loss drug Experts are warning of the possible side…
Novo preparing for early launch of weight-loss drug Wegovy in India
By Rishika Sadam HYDERABAD (Reuters) – Danish drugmaker Novo Nordisk is looking at an early launch of its…